Why did Affy lay off 95% of their R&D Staff first, then get FDA Approval, then recall Omonty (.02% debacle) and lay off 75% of the remaining Employees, then pay off all outstanding debt, then give layoff notices to the rest of Senior Staff, and go public two times talking BK??? Fishy!!
good morning Bill,
how deep are you in affy? I learned the hard way myself, hopefully you are doing well on other stocks
this one is tko'd on its feet and just hasn't fallen yet better get the seat ready trainer, affy is about to grab
some pine for good.
I am so darn tired of hearing about the damn PEARL study from people with no medical background. The PEARL study was study done to see if OMONTYS could be used for patients that were dialysis patients but not on dialysis. The indications for OMONTYS is only for CKD patients on dialysis, so the whole failed PEARL study point is mute.
The fact that gwp point out that these "healthier patients" didn't do well on OMONTYS proves his ignorance on the matter. OMONTYS increases the patients hemaglobin and hematocrit levels after a single dose compared to Epogen/Aransep. When the H/H levels are increased, this means that the number of red blood cells in the body increase.
If the Hemaglobin level becomes greater than 13 g/L, it puts them at risk for heart attacks and strokes. The reason why OMONTYS is not used in so called healthier CKD patients, who are not on dialysis is because it works FAR BETTER than EPOGEN.
So HERE is my statement, if companies likes CLSN, CTIC (w/ a criminal like Jamies Bianco as CEO), and PPHM, are still around, there is no way that AFFY is going bankrupt.
Also bill, don't listen to people like gwp, they skew the facts to suit their own malicious agenda. They have no basis in medicine and make it fairly evident when they bring up things like the PEARL study.
Thanks for explaining for us. I am frustrated with these guys too. Same guy with different aliases, tries to scare people to give up their shares so him and his hedge fund manager can scoop up the cheap shares.
They try to be very educated in this matter and compares APPLES to ORANGES to fulfill their dishonest agenda. Always brings the same old PEARL studies reference without knowing, what is it about. I hope they start earning an honest living, one which doesn't involve cheating and fooling other people with their money.
Remember, when the website was down last weekend. What a BS they wrote on this message board all weekend long. But nothing happened on Monday.
Stupid, arrogant, blood sucking parasites should leave us alone!
Nothing fishy about it at all. Omontys failed. PEARL studies proved Omontys was deadly for the "healthier" CKD patients not on dialysis. At the time the FDA approved Omontys for the "sicker" CKD patients on dialysis, it did so saying it wanted to have competition against the Amgen Epogen/Aranesp monopoly, and imposed post marketing studies to ensure Omontys was safe. Actual patient usage proved Omontys to be unsafe just like the PEARL studies. The FDA, Affymax and Takeda all agreed to withdraw Omontys from the market. A failed drug. No unmet medical need. What more is there to say?
godwin dude, I think a raj just gave you a spankin!!!! a raj find the way to get your new article called "Affymax and Omontys will rise again" put on Seeking Alpha and then have it picked up by Yahoo under Affy News to get top Heading above the bogus Lawsuit Headlines. By the way have you read the Lawsuit complaints? They are full of errors and will be thrown out!!!!